Gorski, J.W.; Zhang, Z.; McCorkle, J.R.; DeJohn, J.M.; Wang, C.; Miller, R.W.; Gallion, H.H.; Dietrich, C.S.; Ueland, F.R.; Kolesar, J.M.
Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance. Biomedicines 2021, 9, 1021.
https://doi.org/10.3390/biomedicines9081021
AMA Style
Gorski JW, Zhang Z, McCorkle JR, DeJohn JM, Wang C, Miller RW, Gallion HH, Dietrich CS, Ueland FR, Kolesar JM.
Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance. Biomedicines. 2021; 9(8):1021.
https://doi.org/10.3390/biomedicines9081021
Chicago/Turabian Style
Gorski, Justin W., Zhuwei Zhang, J. Robert McCorkle, Jodi M. DeJohn, Chi Wang, Rachel W. Miller, Holly H. Gallion, Charles S. Dietrich, Frederick R. Ueland, and Jill M. Kolesar.
2021. "Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance" Biomedicines 9, no. 8: 1021.
https://doi.org/10.3390/biomedicines9081021
APA Style
Gorski, J. W., Zhang, Z., McCorkle, J. R., DeJohn, J. M., Wang, C., Miller, R. W., Gallion, H. H., Dietrich, C. S., Ueland, F. R., & Kolesar, J. M.
(2021). Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance. Biomedicines, 9(8), 1021.
https://doi.org/10.3390/biomedicines9081021
